IconicAlpha
← Back to the wall
DaVita Inc

DaVita Inc

DVA · Healthcare · Health Care

Market cap
$11.74B
Price
$184.03
Daily change
+0.21%
Rank
#459

Updated 6h ago · data delayed ≥15 min

IconicScore

Proprietary
34/ 100
Scale11
Momentum51
Sector leadership12
Brand visibility85

Ranked #452 of 500 by Iconic Score · #53 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.

Score trend · 88d+11 pts
Free · every trading day, 7 AM ET

Get the free morning email

The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →

Price performance

Export history · Analyst
Price$184.03+22.6%
$241$150
Apr 26Oct 26
IconicScore vs. price

This insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.

Upgrade to Analyst
Sector benchmark

This is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.

Upgrade to Enterprise

Iconic Profile

DaVita Inc. (DVA) is a leading provider of kidney care and dialysis services in the United States, operating over 2,800 outpatient dialysis centers and serving approximately 200,000 patients with chronic kidney disease. With a market capitalization of $15.2 billion, DaVita is positioned as a key player in the healthcare sector, focusing on delivering high-quality patient care and innovative treatment options. The company also offers integrated care solutions, including telehealth services and chronic kidney disease management, which enhance patient outcomes and streamline healthcare delivery. DaVita's commitment to improving the quality of life for patients and its strong operational framework make it a significant entity in the evolving healthcare landscape, particularly as the prevalence of kidney disease continues to rise.

IconicOracleAI™ Brief

DaVita Inc's Iconic Score of 33 reflects a challenging brand perception amid recent headlines highlighting stock declines and unusual trading volumes. While the company has reaffirmed its commitment to innovation and patient choice in response to the HHS Kidney Care National Plan, the negative sentiment surrounding its stock performance has impacted overall brand visibility. Despite a strong logo analysis score of 85/100, the current market dynamics suggest a struggle to maintain positive brand momentum.

AI-generated explanation of current score drivers. Not investment advice.

Visit website ↗Compare ⇄Claim this profile

Enterprise tier: claim your logo to manage how your brand is represented.